Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport.

Sun J, Morgan M, Shen RF, Steenbergen C, Murphy E.

Circ Res. 2007 Nov 26;101(11):1155-63. Epub 2007 Oct 4.

2.

Angiotensin II and ischemic preconditioning synergize to improve mitochondrial function while showing additive effects on ventricular postischemic recovery.

Nuñez RE, Castro M, Javadov S, Escobales N.

J Cardiovasc Pharmacol. 2014 Aug;64(2):172-9. doi: 10.1097/FJC.0000000000000103.

3.

Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture.

Kohr MJ, Sun J, Aponte A, Wang G, Gucek M, Murphy E, Steenbergen C.

Circ Res. 2011 Feb 18;108(4):418-26. doi: 10.1161/CIRCRESAHA.110.232173. Epub 2010 Dec 30.

4.

Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria.

Sun J, Nguyen T, Aponte AM, Menazza S, Kohr MJ, Roth DM, Patel HH, Murphy E, Steenbergen C.

Cardiovasc Res. 2015 May 1;106(2):227-36. doi: 10.1093/cvr/cvv044. Epub 2015 Feb 18.

5.

Characterization of the sex-dependent myocardial S-nitrosothiol proteome.

Shao Q, Fallica J, Casin KM, Murphy E, Steenbergen C, Kohr MJ.

Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H505-15. doi: 10.1152/ajpheart.00681.2015. Epub 2015 Dec 23.

6.

Calcium-sensing receptor: a sensor and mediator of ischemic preconditioning in the heart.

Sun J, Murphy E.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1309-17. doi: 10.1152/ajpheart.00373.2010. Epub 2010 Sep 10.

7.

Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury.

Sun J, Picht E, Ginsburg KS, Bers DM, Steenbergen C, Murphy E.

Circ Res. 2006 Feb 17;98(3):403-11. Epub 2006 Jan 5.

8.

Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins.

Sun J, Kohr MJ, Nguyen T, Aponte AM, Connelly PS, Esfahani SG, Gucek M, Daniels MP, Steenbergen C, Murphy E.

Antioxid Redox Signal. 2012 Jan 1;16(1):45-56. doi: 10.1089/ars.2010.3844. Epub 2011 Aug 11.

9.

In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine.

Nadtochiy SM, Burwell LS, Ingraham CA, Spencer CM, Friedman AE, Pinkert CA, Brookes PS.

J Mol Cell Cardiol. 2009 Jun;46(6):960-8. doi: 10.1016/j.yjmcc.2009.01.012. Epub 2009 Feb 3.

10.
11.

Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.

Balakumar P, Singh H, Reddy K, Anand-Srivastava MB.

J Cardiovasc Pharmacol. 2009 Sep;54(3):204-12. doi: 10.1097/FJC.0b013e3181b04cc5.

PMID:
19568176
12.
13.
14.

Ca2+ as a mediator of ischemic preconditioning.

Miyawaki H, Ashraf M.

Circ Res. 1997 Jun;80(6):790-9.

15.

Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection.

Lin J, Steenbergen C, Murphy E, Sun J.

Circulation. 2009 Jul 21;120(3):245-54. doi: 10.1161/CIRCULATIONAHA.109.868729. Epub 2009 Jul 6.

16.

eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.

Talukder MA, Yang F, Shimokawa H, Zweier JL.

Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H437-45. doi: 10.1152/ajpheart.00384.2010. Epub 2010 Jun 4.

17.

Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.

Serejo FC, Rodrigues LF Jr, da Silva Tavares KC, de Carvalho AC, Nascimento JH.

J Cardiovasc Pharmacol. 2007 Apr;49(4):214-20.

PMID:
17438406
18.

Mitochondrial function during ischemic preconditioning.

Crestanello JA, Doliba NM, Babsky AM, Doliba NM, Niibori K, Osbakken MD, Whitman GJ.

Surgery. 2002 Feb;131(2):172-8.

PMID:
11854695
19.

Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?

Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM.

Cardiovasc Res. 2002 Aug 15;55(3):534-43.

PMID:
12160950
20.

Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction.

Talukder MA, Kalyanasundaram A, Zhao X, Zuo L, Bhupathy P, Babu GJ, Cardounel AJ, Periasamy M, Zweier JL.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2418-28. Epub 2007 Jul 13.

Supplemental Content

Support Center